Liquid Biopsy in <i>EGFR</i>-Mutated Advanced NSCLC from T790M to <i>MET</i> Amplification: Clinical Implications and Possibilities in the Resistance Setting

• 主要な著者: Luigi Della Gravara (著者), Ciro Battiloro (著者), Aniello Avellino (著者), Francesca Caputo (著者), Carmine D'Aniello (著者), Danilo Rocco (著者)
• フォーマット: 図書
• 出版事項: MDPI AG, 2023-04-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

According to the ESMO and ASCO clinical guidelines, the main role of liquid biopsy in <i>EGFR</i>+ advanced NSCLC patients is represented by T790M detection after erlotinib/gefitinib/afatinib progression. However, the general international expert consensus regards osimertinib as the pref...